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OBJECTIVES This study examined the effect of brief duration atrial fibrillation on left atrial and left atrial
appendage mechanical function in humans with structural heart disease.
BACKGROUND Left atrial dysfunction and the development of spontaneous echo contrast (SEC) may follow
the cardioversion of atrial fibrillation (AF) to sinus rhythm. This phenomenon has been
termed “stunning” and is implicated in the development of atrial thrombus and embolic
stroke. The effects of brief duration AF on left atrial mechanical function in humans are
unknown.
METHODS Twenty-four patients (23 men, aged 59.1 6 12.7 years) with significant structural heart
disease (ejection fraction 31.2 6 9.0%, left atrial diameter 4.9 6 0.4 cm) undergoing
implantation of a ventricular cardiodefibrillator underwent transesophageal echocardiography
to evaluate left atrial appendage emptying velocities (LAAeV) and SEC before, during and
after a 15-min period of AF induced by rapid right atrial pacing. Atrial fibrillation was then
permitted to terminate spontaneously within 5 min or was reverted with an endocardial direct
current shock. Velocities and SEC were assessed in sinus rhythm pre-AF, during AF and
immediately, 5 and 10 min after reversion to sinus rhythm.
RESULTS Atrial fibrillation terminated spontaneously in 10 patients after 16.1 6 1.0 min. Endocardial
direct current (DC) cardioversion of 10.4 6 6.4 J was required in 14 patients after AF lasting
20 min. Mean LAAeV pre-AF (50.0 6 17.5 cm/s) was not significantly different to LAAeV
immediately (52.8 6 16.7 cm/s), 5 min (54.3 6 16.4 cm/s) or 10 min (53.7 6 15.7 cm/s) after
reversion to sinus rhythm. Atrial stunning defined as a reduction in LAAeV of .20% was not
observed in any patient. Fourteen of 24 patients (58%) developed SEC during AF, which
resolved within 30 s of AF termination. There were no significant differences between
LAAeV in those patients reverting with DC shock (pre-AF 50.6 6 16.2 cm/s vs. immediately
post-AF 54.7 6 16.6 cm/s) or in those patients with spontaneous reversion (pre-AF 48.9 6
20.2 cm/s vs. immediately post-AF 49.8 6 17.3 cm/s).
CONCLUSIONS Significant left atrial stunning was not observed after brief duration AF in humans with
structural heart disease. Transient left atrial SEC develops in a significant proportion of these
patients during AF but resolves rapidly on reversion to sinus rhythm. These findings suggest
that the risk of thromboembolism may be low after brief duration AF that terminates either
spontaneously or with an endocardial DC shock even in patients with significant structural
heart disease. These findings have important implications for recipients of implantable
devices that are capable of atrial defibrillation in response to AF. (J Am Coll Cardiol 1999;
33:342–9) © 1999 by the American College of Cardiology
The cardioversion of atrial fibrillation (AF) to sinus rhythm
is associated with mechanical dysfunction of the left atrium
(LA) and the development of spontaneous echo contrast
(SEC) (1–3). This phenomenon has been termed “stun-
ning” and is implicated in the development of embolic
stroke after cardioversion of AF. The mechanism of atrial
stunning is incompletely understood, but some evidence
suggests that it represents a form of tachycardia-mediated
atrial mechanical remodeling (4,5).
Recent evidence clearly demonstrates that electrical re-
modeling of the human atrium may occur with AF duration
as short as 7 to 8 min and be sufficient to promote
subsequent episodes of AF (6–8). The underlying mecha-
nisms responsible for both electrical and mechanical remod-
eling of the atrium may be similar. Whether atrial mechan-
ical remodeling or “stunning” also develops after such brief
durations of AF is unknown.
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We prospectively determined the effects of brief dura-
tion AF on LA and left atrial appendage (LAA) mechan-
ical function in patients with structural heart disease
using transesophageal echocardiography (TEE).
METHODS
Patients. Twenty-four patients in sinus rhythm undergo-
ing nonthoracotomy implantation of a ventricular implant-
able cardioverter defibrillator (ICD) for accepted indications
were recruited for this research investigation. All patients
were either survivors of resuscitated sudden cardiac death or
had rapid ventricular tachycardia or ventricular fibrillation
induced at electrophysiologic study. Demographic details
are described in Table 1. All patients underwent trans-
thoracic echocardiography to determine LA size and gated
single-photon emission computed tomographic scanning to
assess left ventricular function prior to ICD implantation.
All patients had significant structural heart disease with left
ventricular dysfunction; the mean left ventricular ejection
fraction was 31.2 6 9.0%. Left atrial enlargement was
present in all patients (4.9 6 0.4 cm, range 4.2 cm to
5.5 cm), and 9/24 patients (33%) had a clinical history of
paroxysmal AF. No patient had a history of stroke or
transient ischemic attacks related to chronic or paroxysmal
AF. All patients were receiving chronic antiarrhythmic
therapy, which was not ceased prior to ICD implantation.
No patient received therapy with specific calcium antago-
nists. All patients gave written informed consent to the
study, which was approved by the Board of Medical
Research of The Royal Melbourne Hospital.
Implantable cardioverter defibrillator implantation pro-
cedure. A standardized general anesthetic was adminis-
tered to all patients. This comprised induction with an
intravenous propofol (Diprivan) infusion, followed by anes-
thesia maintained with the volatile agent isoflurane and the
muscle relaxant atracurium. All devices were implanted in
the left prepectoral position with the ventricular endocardial
leads placed at the right ventricular apex.
Induction of atrial fibrillation. After ICD implantation,
AF was induced by rapid right atrial pacing at an output of
5 mA at a drive cycle length of 150–200 ms employing one
of two methods: i) pacing from a 6-F quadripolar Josephson
temporary electrode introduced via the right femoral vein,
placed in the right atrial appendage and connected to a
Medtronic 5325 programmable stimulator (n 5 19); or ii)
pacing from the permanent atrial lead of the ICD if a dual
chamber device with atrial pacing capability was selected for
implantation (n 5 5). After induction of AF, the surface
electrocardiogram was monitored continuously to ensure
that AF persisted. If AF reverted spontaneously prior to a
total of 15 min duration, AF was immediately reinduced by
rapid right atrial pacing.
After 15 min of AF, the arrhythmia was permitted to
terminate spontaneously within 5 min. If AF did not
terminate spontaneously during this 5-min interval, an
endocardial direct current (DC) shock was delivered from
the ICD to revert AF to sinus rhythm after a total of
20 min. Patients in whom AF could not be induced and
maintained for more than a few seconds after 20 rapid atrial
pacing attempts were excluded from further study.
Implantable cardioverter defibrillator shock vector,
waveform and direct current shock delivery. Direct cur-
rent cardioversion of AF to sinus rhythm was achieved by
employing increasing endocardial shock energies. An initial
attempt at 5 J was made, followed by a 10-J then 20-J shock
if the prior attempt was unsuccessful. All endocardial shocks
were delivered between the right ventricular cathode and the
ICD generator anode and synchronized to the R wave of the
intrinsic QRS complex. Shock energy, synchronization and
delivery were controlled via telemetry of the ICD system.
No patients required transthoracic DC shock delivery or
additional antiarrhythmic agents for cardioversion of AF.
Echocardiographic analysis. Left atrial and LAA function
were assessed at six defined time points:
1. In sinus rhythm 1 min before induction of AF.
2. After induction of AF at 1 min.
3. After induction of AF at 10 min.
4. Immediately after reversion of AF to sinus rhythm.
Abbreviations and Acronyms
AF 5 atrial fibrillation
DC 5 direct current
ICD 5 implantable cardioverter defibrillator
LA 5 left atrium/left atrial
LAA 5 left atrial appendage
SEC 5 spontaneous echo contrast
TEE 5 transesophageal echocardiography
Table 1. Clinical and Echocardiographic Characteristics of the
Patient Population Undergoing Induction of Brief Duration
Atrial Fibrillation
Total 24
Age (years) 59.1 6 12.7
Male 23 (96%)
History of AF 8 (33%)
Ischemic cardiomyopathy 16 (67%)
Dilated cardiomyopathy 8 (33%)
LVEF% 31.2 6 9.0
LA size (cm) 4.9 6 0.4
LVESD (cm) 4.9 6 0.9




AF 5 atrial fibrillation; LA 5 left atrial; LVEDD 5 left ventricular end diastolic
diameter; LVEF 5 left ventricular ejection fraction; LVESD 5 left ventricular end
systolic diameter.
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5. In sinus rhythm 5 min after reversion.
6. In sinus rhythm 10 min after reversion.
All recordings were performed during apnea to minimize
potential velocity variations caused by mechanical ventila-
tion. Transesophageal echocardiography was performed us-
ing a 5-MHz phased array multiplane probe attached to a
Hewlett-Packard Sonos 2500 ultrasound system. Images
were recorded on half-inch super VHS tape and analyzed
off-line using Hewlett-Packard software. All velocity mea-
surements were performed off-line and averaged over 20
consecutive cardiac cycles.
Left atrial appendage emptying velocities were assessed
using pulse wave Doppler placing the sample volume 1 cm
into the mouth of the LAA. A multiplane probe was used to
scan the appendage from 0° to 180° in the transverse plane
to establish an angle at which maximum flow velocities
could be obtained. This angle was retained for subsequent
analysis. Left atrial function was assessed with TEE pulse
wave Doppler interrogation of the mitral inflow A waves
with the sample volume placed at the level of the mitral
valve leaflet tips. Mitral inflow A waves were not assessed
during AF and were evaluated at time points 1, 4, 5 and 6
only.
Left atrial appendage stunning was defined as a reduction
in LAA velocities in sinus rhythm of $20% after AF
compared with velocities in sinus rhythm before AF (1).
Spontaneous echo contrast was evaluated at the six time
points as described above. This was defined as swirling
patterns of echogenicity in the LA and LAA distinct from
white noise artifact. Gain settings were reduced in a
sequential manner to distinguish echocardiographic contrast
from noise artifact and maintained for the duration of the
study. Spontaneous echo contrast was graded independently
by two observers based on the description of Daniel et al.
(9). The development of SEC preceding, during and after
AF was determined by consensus. Analysis was performed
off-line, and each echocardiographer was blinded to the
other’s interpretations. Left atrial appendage thrombus was
defined as a mass adherent to the wall of the LAA
displaying either independent motion or different echogenic
density (9).
Statistical analysis. All measurements are presented as
mean 6 standard deviation. A repeated measures analysis of
variance was used to compare continuous variables. Scheffe´
F test was used for multiple comparisons. In comparing
patient subgroups, differences between continuous variables
were assessed with the unpaired Student t test. Differences
between categoric variables were evaluated with 2 3 2
contingency tables with the chi-square test. Statistical sig-
nificance was established at p , 0.05. The study was
prospectively designed with 90% power to detect a mean fall
in LAA velocity of 14 6 13 cm/s after spontaneous or
electrical cardioversion from AF (1). At least 10 patients in
each group were required to detect this difference (10).
RESULTS
Atrial fibrillation induction and termination. Five pa-
tients who consented to the study were excluded from
analysis, as AF could not be induced despite 20 attempts at
rapid right atrial pacing. A dual chamber ICD was im-
planted in 5/24 patients (21%) and was used to induce AF
via the permanent atrial electrode positioned in the right
atrial appendage. In the remaining 19 patients (79%), AF
was induced via a temporary pacing electrode positioned in
the right atrial appendage. The mean number of AF
inductions for the patient population was 3.3 6 3.5 (range
1 to 15). The mean ventricular rate during AF was 87 6
10/min at 1 min and 91 6 11/min at 10 min.
Spontaneous termination of AF occurred in 10 patients
(42%). The mean duration of AF prior to termination in this
group was 16.1 6 1.0 min. Endocardial shocks were delivered
in the remaining 14 patients in whom spontaneous reversion
did not occur by 20 min. The mean duration of AF in this
group was 20.9 6 1.0 min, which was significantly longer than
in the group of those in whom AF terminated spontaneously
(p , 0.001). The mean endocardial DC shock energy deliv-
ered for reversion was 10.4 6 6.4 J.
Left atrial appendage function. Mean LAA velocity prior
to AF induction was 50.0 6 17.4 cm/s. During AF, the
mean LAA velocity decreased significantly to 37.9 6 10.7
cm/s at 1 min (p , 0.01) and to 38.1 6 10.9 cm/s at 10 min
(p , 0.01) compared with sinus rhythm prior to induction
of AF. There were no significant differences between mean
LAA velocities immediately (52.8 6 16.7 cm/s), 5 min
(54.3 6 16.4 cm/s) and 10 min after reversion from AF
(53.7 6 15.7 cm/s) compared with the mean LAA velocity
prior to AF induction (Fig. 1).
Mode of reversion. There were no significant differences
between LAA velocities before and immediately, 5 min and
10 min after AF in those patients reverting specifically with
endocardial DC shocks. Similarly, there were no significant
differences between LAA velocities before and immediately,
5 min and 10 min after cardioversion from AF in those
patients reverting spontaneously (Table 2). There were no
significant differences between the electrical reversion versus
spontaneous reversion groups in terms of ejection fraction
(32.8 6 9.3% vs. 28.3 6 8.3%), LA dimensions (4.9 6
0.4 cm vs. 5.0 6 0.4 cm), age (59.8 6 15.5 years vs. 58.1 6
7.1 years) or antiarrhythmic therapy (43% sotalol vs. 40%
sotalol).
Antiarrhythmic therapy. There were no significant differ-
ences between LAA velocities before and immediately,
5 min and 10 min after reversion from AF in those patients
taking chronic amiodarone therapy. Similarly, there were no
significant differences between LAA velocities before and
immediately, 5 min and 10 min after reversion from AF in
those patients taking chronic sotalol therapy (Table 3, Fig.
2). There were no significant differences between the
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amiodarone versus sotalol groups in terms of ejection
fraction (31.1 6 8.9% vs. 31.3 6 9.8%), LA size (5.0 6
0.3 cm vs. 4.7 6 0.5 cm), age (60.8 6 6.7 years vs. 56.9 6
18.0 years) and endocardial shock reversion (57% vs. 70%).
Left atrial appendage stunning. Immediately after rever-
sion of AF to sinus rhythm, no patients demonstrated
evidence of LAA stunning (defined as a decrease in LAA
velocity of $20% [1]). However, three of the 24 patients
demonstrated LAA velocity decreases in the range of 15%
to 20%. The mean decrease in LAA velocity in these three
patients was 16.3 6 1.8%, which represented a mean
absolute reduction of 10.6 6 1.2 cm/s. After 5 min of
sustained sinus rhythm, these velocities returned to within
5% of the pre-AF value in all three patients. Left atrial SEC
did not develop after reversion to sinus rhythm in these
patients. Interestingly, these three patients reverted to sinus
rhythm spontaneously without requiring a DC shock.
Left atrial function. For the total study population, the
mean late mitral A wave velocity prior to AF induction was
38.3 6 11.8 cm/s. This was not significantly different from
that immediately (39.4 6 10.0 cm/s), 5 min (40.0 6 10.3
cm/s), or 10 min (39.7 6 10.4 cm/s) after AF termination.
Mode of reversion. In those patients reverting from AF
with endocardial DC shocks, there were no significant
differences between late mitral A wave velocities before and
immediately, 5 min and 10 min after reversion. Similarly,
there were no significant differences in late mitral inflow A
wave velocities before and immediately, 5 min and 10 min
after AF in those patients reverting spontaneously (Table 2).
Antiarrhythmic therapy. There were no significant differ-
ences between late mitral A wave velocities before and
immediately, 5 min and 10 min after cardioversion from AF
in those patients taking chronic amiodarone therapy. Sim-
ilarly, there were no significant differences in late mitral
inflow A wave velocities before and immediately, 5 min and
10 min after cardioversion from AF in those patients taking
chronic sotalol therapy (Table 3).
Left atrial spontaneous echo contrast. One patient dem-
onstrated light LA SEC before induction of AF. During
AF, 14 patients (58%) demonstrated new or increased LA
SEC. Light SEC was present in 11 patients, and dense
SEC was present in three patients. In all patients, change in
SEC grade developed within 30 s and did not change in
terms of classification (i.e., light vs. dense) during AF. No
Figure 1. Left atrial appendage flow velocity changes before and during atrial fibrillation and after cardioversion from atrial fibrillation to
sinus rhythm. Note the significant differences between velocities during atrial fibrillation (*) and sinus rhythm (†) (p , 0.01). There were
no significant differences between velocities in sinus rhythm before atrial fibrillation and after cardioversion from brief duration atrial
fibrillation. AF 5 atrial fibrillation; SR 5 sinus rhythm.
Table 2. Left Atrial Appendage Velocity and Mitral A Wave Velocities Before, During and After Brief Duration Atrial Fibrillation
in Patients Reverting With an Endocardial Shock (n 5 14) or Spontaneously (n 5 10)
SR Pre-AF AF 1 min AF 10 min SR 0 min SR 5 min SR 10 min
LAAeV (cm/s)
(shock)
50.6 6 16.2 36.1 6 11.5 37.3 6 11.7 54.7 6 16.6 56.0 6 14.9 56.1 6 14.3
LAAeV (cm/s)
(spontaneous)
48.9 6 20.2 40.8 6 9.4 39.5 6 10.0 49.8 6 17.3 51.7 6 19.0 49.9 6 17.9
MVA (cm/s)
(shock)
37.7 6 13.2 — — 38.0 6 9.7 38.6 6 9.5 37.9 6 10.3
MVA (cm/s)
(spontaneous)
40.3 6 5.5 — — 43.4 6 11.8 44.3 6 13.6 44.5 6 11.0
AF 5 atrial fibrillation; LAAeV 5 left atrial appendage emptying velocity; MVA 5 mitral A wave velocity; shock 5 cardioversion with endocardial direct current shock;
spontaneous 5 spontaneous cardioversion; SR 5 sinus rhythm after cardioversion from AF at 0, 5 and 10 min.
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patient developed LA or LAA thrombus. After reversion to
sinus rhythm, LA SEC resolved in all but the single patient
with baseline SEC within 30 s.
In those patients who developed new or increased LA
SEC during AF, the mean LAA velocities during AF after
1 and 10 min of AF were 34.7 6 10.5 cm/s and 34.4 6
10.7 cm/s respectively. These values were significantly less
than the mean LAA velocities after 1 min (43.7 6 9.0 cm/s)
and 10 min (45.2 6 7.6 cm/s) of AF in those patients who
did not develop LA SEC (p , 0.05). There were no
significant differences in the SEC group versus the group
with no SEC in terms of LA size (4.9 6 0.4 cm vs. 5.0 6
0.4 cm), ejection fraction (32.3 6 9.7% vs. 28.5 6 6.3%) or
antiarrhythmic therapy (36% sotalol vs. 50% sotalol).
Heart rate. The mean heart rate in sinus rhythm for the
total population before AF induction (62 6 8/min) was not
significantly different from that immediately after reversion
to sinus rhythm (61 6 8/min), 5 min after AF (62 6 7/min)
or 10 min after AF (63 6 9/min).
Follow-up. All patients were reviewed 3 months after the
research protocol and ICD implantation. Four of the 24
patients (17%) developed spontaneous AF during this




The present study produced the following findings: 1) a 15
to 20 min period of AF that reverts spontaneously or with
an endocardial shock is not associated with LA stunning in
humans with structural heart disease; 2) LA SEC develops
in many of these patients during acute AF but resolves
rapidly on reversion to sinus rhythm; and 3) chronic therapy
with sotalol or amiodarone is not associated with LA
stunning after cardioversion from acute AF.
Background: Mechanical and
Electrical Remodeling of the Atria
Left atrial stunning is considered an important mechanism
responsible for embolic stroke occurring after the cardiover-
sion of AF, and anticoagulation is recommended if AF has
been present for more than 48 h to reduce the risk of stroke
(2,3,11–13). Whether LA stunning occurs after cardiover-
sion of AF that has been present for ,48 h is unknown.
Although the effects of short duration AF on atrial
mechanical function are unknown, recent work has shown
that even brief episodes of AF may be sufficient to induce
electrical remodeling of the atria (6–8). After 8 min of AF
in patients without structural heart disease, Daoud et al.
demonstrated that atrial effective refractory periods de-
crease, and AF becomes more easily inducible and sustain-
able (7).
Whether the mechanisms responsible for electrical re-
modeling in AF also contribute to mechanical remodeling is
unknown. Nevertheless, the observation that “AF begets
AF” as a result of electrical remodeling has created an
imperative to intervene early after AF onset to prevent these
effects (14,15). Indeed, the rationale for an implantable
atrial defibrillator is at least in part premised on the notion
that the cycle of electrical remodeling and propensity to AF
Figure 2. A comparison between left atrial appendage flow veloc-
ities in sinus rhythm, pre–atrial fibrillation and immediately
(0 min), 5 min and 10 min after cardioversion from brief atrial
fibrillation in individual patients taking either amiodarone
(squares) or sotalol (diamonds). There were no significant differ-
ences between velocities in sinus rhythm before atrial fibrillation
and after cardioversion from brief duration atrial fibrillation in
patients taking either amiodarone or sotalol. SR 5 sinus rhythm.
Table 3. Left Atrial Appendage Velocity and Mitral A Wave Velocities Before, During and After Brief Duration Atrial Fibrillation
in Patients Taking Chronic Amiodarone Therapy (n 5 14) or Chronic Sotalol Therapy (n 5 10)
SR Pre-AF AF 1 min AF 10 min SR 0 min SR 5 min SR 10 min
LAAeV (cm/s)
(amiodarone)
49.4 6 16.7 35.7 6 11.2 34.5 6 10.7 53.5 6 17.2 53.4 6 15.8 53.1 6 15.5
LAAeV (cm/s)
(sotalol)
50.7 6 19.3 41.1 6 9.0 43.2 6 8.2 51.7 6 16.8 55.5 6 17.9 54.5 6 16.8
MVA (cm/s)
(amiodarone)
45.0 6 7.1 — — 42.3 6 6.3 43.0 6 4.7 43.1 6 5.8
MVA (cm/s)
(sotalol)
34.5 6 12.5 — — 37.2 6 12.3 37.9 6 13.3 37.7 6 12.3
AF 5 atrial fibrillation; LAAeV 5 left atrial appendage emptying velocity; MVA 5 mitral A wave velocity; SR 5 sinus rhythm after cardioversion from AF at 0, 5 and 10 min.
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may be reversed by early restoration of sinus rhythm, and
preliminary evidence suggests this may be true (16). It is
imperative to know whether short duration AF is associated
not only with electrical but also mechanical remodeling of
the atrium. Reversion to sinus rhythm early after AF onset
may be associated with atrial stunning and hence a propen-
sity to embolic stroke.
Risk Factors for Mechanical
Remodeling and Atrial Stunning
Structural heart disease. We hypothesized that patients
undergoing ICD implantation with both LA enlargement
and left ventricular dysfunction would be at high risk for
atrial stunning after brief duration AF (11,17,18). Despite
this patient selection no evidence of atrial stunning after AF
of up to 20 min duration was demonstrated. Our results
conflict with those of a preliminary study examining the
effects of brief duration AF in patients without structural
heart disease in which LAA velocities decreased from
70 cm/s to 62 cm/s after 15 min of AF (19). Although this
result was statistically significant, it may be questioned
whether the reduction is of clinical significance, as LAA
velocities associated with SEC and thrombus are usually less
than 20 cm/s (1–3).
In the present study, only 8/24 patients (33%) had a
history of paroxysmal AF, and mean LAA velocities at
baseline and during AF were greater than those usually
associated with LA thrombus and embolic stroke (2). In the
presence of more advanced atrial dysfunction at baseline,
brief duration AF may have been associated with atrial
stunning. This is an important issue that should be the focus
of future research.
Antiarrhythmic drugs. Although there is evidence that
calcium antagonists may attenuate electrical remodeling
(6,8,15), the effect of antiarrhythmic agents on atrial me-
chanical function has not yet been established. Transient
atrial mechanical dysfunction after 10 min of AF has been
demonstrated in a porcine model (20). This was attenuated
by verapamil and exacerbated by BAY K8644, suggesting
transsarcolemmal calcium flux to be an important determi-
nant of atrial stunning. Sotalol may aggravate atrial stunning
after cardioversion of AF in humans (21).
In the present study, all patients were taking sotalol or
amiodarone, and no evidence of atrial stunning after brief
duration AF was found in either group. It has been shown
that neither of these drugs prevents atrial electrical remod-
eling (8). Although it cannot be excluded that the common
actions of these agents (class III or beta-blockade) prevented
atrial stunning, we believe this to be unlikely in the face of
available evidence (8,21).
Mode of reversion. Controversy exists as to whether elec-
trical energy is an important determinant of atrial stunning
after cardioversion (2,18,22). Recently it has been demon-
strated that endocardial and external shocks delivered in
sinus rhythm do not affect LA function (23). Furthermore,
significant LA stunning occurs when chronic atrial flutter is
reverted with radiofrequency ablation (in the absence of DC
shocks), thus suggesting that stunning results from the atrial
arrhythmia and not the mode of reversion (24). In the
present study, LA stunning was not observed in patients
who reverted either spontaneously or with endocardial
shocks.
Development of SEC during AF. In this study, LA SEC
developed in 58% of patients within 30 s of the development
of AF. The mean LAA velocity during sinus rhythm was
47.8 cm/s, but fell to 34.4 cm/s with AF at 10 min (Table
4). The rapid appearance of SEC is consistent with previous
reports demonstrating SEC in 39% to 87% of patients with
paroxysmal AF and AF lasting ,3 days (2,25,26). In
patients with chronic AF, SEC is associated with LA
thrombus and is an independent predictor of stroke and
mortality (2,27). The implications of SEC developing early
after a paroxysm of AF are unknown. Nevertheless, it is a
concern that 10 min of AF was sufficient to allow SEC to
form in a proportion of patients. Indeed, SEC was seen as
a result of AF onset and not as a result of atrial mechanical
remodeling, which is a consequence of chronic AF (4,13).
Whether these acute changes in LA function are sufficient
for thrombus to form without the requirement for atrial
mechanical remodeling is unknown.
Table 4. Left Atrial Appendage Velocity and Mitral A Wave Velocities Before, During and After Brief Duration Atrial Fibrillation
in Patients With (n 5 14) and Without (n 5 10) Spontaneous Echocardiographic Contrast During AF
SR Pre-AF AF 1 min AF 10 min SR 0 min SR 5 min SR 10 min
LAAeV (cm/s)
(LASEC)
47.5 6 18.3 34.7 6 10.5 34.4 6 10.7 52.5 6 17.6 52.8 6 17.7 52.4 6 17.4
LAAeV (cm/s)
(No LASEC)
54.5 6 15.9 43.7 6 9.0 45.2 6 7.6 53.2 6 16.0 57.1 6 14.1 56.1 6 12.6
MVA (cm/s)
(LASEC)
37.3 6 12.5 — — 40.2 6 9.5 40.9 6 10.0 40.4 6 10.1
MVA (cm/s)
(No LASEC)
40.8 6 11.1 — — 36.7 6 13.3 37.3 6 13.0 37.8 6 13.4
AF 5 atrial fibrillation; LAAeV 5 left atrial appendage emptying velocity; LASEC 5 left atrial spontaneous echocardiographic contrast; MVA 5 mitral A wave velocity; SR 5
sinus rhythm after cardioversion from AF at 0, 5 and 10 min.
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Resolution of SEC after cardioversion. The severity of
LA stunning after cardioversion relates to the chronicity of
preceding AF, and a tachycardia-mediated atrial cardiomy-
opathy is considered a potential cause (1,4,5,13,15). In the
current study, cardioversion from brief AF was not associ-
ated with a reduction in LAA velocities but a prompt return
to pre-AF velocities and rapid resolution of SEC. Presum-
ably, AF in these circumstances is not of sufficient duration
to induce the atrial mechanical remodeling observed with
cardioversion of chronic AF (4,13).
Clinical implications. The efficacy of low energy endocar-
dial defibrillation for AF has been demonstrated by several
groups, and a multicenter study examining the feasibility of
an implantable atrial defibrillator is in progress (28). Data
demonstrate that the majority of patients with paroxysmal
forms of AF can be successfully cardioverted with energy
levels of ,5 J (28). Levy and Camm have emphasized the
importance of specific and safe therapy if the implantable
atrial defibrillator is to become an acceptable mode of
therapy for paroxysmal AF (29). Whether endocardial DC
cardioversion of brief duration AF by such a device is
complicated by LA stunning and hence stroke has not been
previously determined. The present study demonstrates that
patients with an implantable atrial defibrillator as a stand-
alone device or as a component of a ventricular ICD are not
at risk of developing atrial mechanical dysfunction as a result
of endocardial cardioversion after AF of brief duration.
Thromboembolic stroke risk related to atrial stunning in
these circumstances is presumably low, and anticoagulation
after endocardial shock reversion of brief duration AF may
not be necessary.
Programmed stimulation during electrophysiologic stud-
ies may be complicated by AF. Endocardial defibrillation
through predeployed intracardiac catheters allows rapid
reversion to sinus rhythm and facilitates continuation of the
procedure (28). Findings from the present study suggest
that cardioversion in these circumstances where AF has
lasted less than 20 min would not be associated with atrial
stunning.
Limitations. In the present study, immediate reinduction
of AF with rapid atrial pacing was performed within one
R-R interval if spontaneous reversion to sinus rhythm
occurred. Such paroxysms of AF may not necessarily lead to
the same electrical and mechanical remodeling as produced
by continuous AF of the same duration. However, a very
similar stimulation protocol to that used in other studies
that have demonstrated electrical remodeling of the atria
after either rapid atrial pacing or AF induction was used
(6–8), and as atrial electrical remodeling persists for 6 to
8 min after reversion to sinus rhythm, a very brief pause in
AF or rapid atrial pacing would be unlikely to prevent atrial
electrical remodeling. Wijffels et al. also demonstrated that
significant atrial electrical remodeling developed after peri-
ods of intermittent AF and atrial pacing that were separated
by brief periods of spontaneous termination to sinus rhythm
(14).
This study has not defined the duration of AF after which
atrial mechanical dysfunction develops and atrial stunning
becomes a significant problem after cardioversion. The
present study suggests that AF lasting more than 20 min but
less than 48 h may be sufficient to induce atrial mechanical
remodeling and be associated with stunning after reversion
(2,13,25). This underscores the potential importance of an
atrial defibrillator that will be capable of effecting cardio-
version within a period of less than 20 min and potentially
obviate the need for chronic anticoagulation to prevent
embolic stroke in these circumstances. As only one 15- to
20-min episode of AF was induced, the cumulative effect of
sequential episodes of AF and multiple cardioversions can-
not be determined. It is conceivable that many such episodes
of AF followed by cardioversion may lead to atrial stunning.
Conclusions. Significant LA stunning does not occur after
brief duration AF in humans with significant structural
heart disease. Transient LA SEC develops in a significant
proportion of these patients during AF but resolves rapidly
on reversion to sinus rhythm. These findings suggest that
the risk of thromboembolism may be low after brief dura-
tion AF that terminates either spontaneously or with an
endocardial DC shock even in patients with significant
structural heart disease taking concomitant antiarrhythmic
therapy. Our findings are consistent with the current Amer-
ican Heart Association guidelines suggesting that anticoag-
ulation would not be required at the time of cardioversion of
brief duration AF in patients with structural heart disease
(11). These findings have potentially important implications
for recipients of implanted devices who may receive cardio-
verting endocardial shocks after AF of brief duration.
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